18F-FDG PET/CT、MRI与CE-CT筛选适合消融的结直肠肝转移瘤的成本效果分析
本研究采用马尔可夫模型,基于美国医疗体系比较MRI、PET/CT和CE-CT筛选适合消融的结直肠肝转移瘤的长期成本效果。结论认为MRI是最具成本效果的策略,应视为金标准。
要点
- MRI筛选可消融结直肠肝转移瘤的长期成本效果最优。
- CE-CT成本略低于MRI但QALYs稍低,PET/CT成本最高且QALYs未增加。
- 以10万美元支付意愿阈值判断,MRI为推荐影像策略。
核心结论
- MRI是筛选适合消融的结直肠肝转移瘤最具成本效果的影像策略,应视为金标准。
研究设计与样本
- 研究采用马尔可夫模型进行成本效果分析,输入参数来自已发表研究。
- 通过3万次蒙特卡洛模拟进行敏感性分析以验证计算确定性。
- 支付意愿阈值为10万美元,所有计算基于美国医疗体系。
临床应用与阅片要点
- 在筛选结直肠肝转移瘤消融候选者时,可优先考虑MRI以平衡长期成本与健康产出。
- CE-CT可作为成本略低但健康产出稍逊的替代选择。
- PET/CT成本最高且未显示QALYs优势,需结合具体情况谨慎使用。
局限性
- 研究基于美国医疗体系的计算,结论外推至其他医疗体系需谨慎。
- 模型输入参数来自已发表研究,可能存在参数不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Colorectal cancers (CRC) are among the world's most prevailing cancer entities. In a third of all cases, the patients have already developed distant metastases - mainly in the liver - at the time of detection. Colorectal liver metastases (CRLM) can be treated by surgical resection or, as is possible in most cases, by percutaneous ablation. For selecting the liver metastases eligible for radiofrequency ablation (RFA) or microwave ablation (MWA), the common imaging modalities are magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT), and contrast-enhanced computed tomography (CE-CT). This study aims to evaluate those imaging modalities for selecting liver lesions eligible for ablation according to their long-term cost-effectiveness.
MATERIALS AND METHODS: A Markov model was applied, calculating quality-adjusted life years (QALYs) and accumulative costs for every diagnostic strategy, according to predefined input parameters obtained from published research. Further, sensitivity analyses were executed to prove the certainty of the calculations by running Monte-Carlo simulations with 30,000 reiterations. The Willingness-to-pay (WTP) is at $ 100,000. All calculations are based on the U.S. healthcare system.
RESULTS: CE-CT caused cumulative costs of $ 31,940.98 and 8,99 QALYs, whereas MRI caused $ 32,070.83 and 9,01 QALYs. PET/CT caused cumulative costs of $ 33,013.21 and 8,99 QALYs.
CONCLUSION: In conclusion, according to our analysis, MRI is the most cost-effective strategy for detecting liver metastases eligible for ablation and therefore should be seen as the gold standard.
引用
- Schnitzer, Buchner, Biechele, et al. Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis. Eur J Radiol. 2023. PMID: 37004464. doi:10.1016/j.ejrad.2023.110803
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。